The nanoparticles of polylactide (PLA) and poly(lactide-co-glycolide) (PLGA) were prepared by the bi-nary organic solvent diffusion method. The yield, particle size and size distribution of these nanoparticles wereeva...The nanoparticles of polylactide (PLA) and poly(lactide-co-glycolide) (PLGA) were prepared by the bi-nary organic solvent diffusion method. The yield, particle size and size distribution of these nanoparticles wereevaluated. The yield of nanoparticles prepared by this method is over 90%, and the average size of the nanoparticlesis between 130-180 nm. In order to clarify the effect of the organic solvent used in the system on nanoparticle yieldand size, the cloud points of PLA and PLGA were examined by cloud point titration. The results indicate that theyields of nanoparticles increase with the increase of ethanol in the acetone solution and attain the maximum at thecloud point of ethanol, while the size of nanoparticles decreases with the increase of ethanol in the acetone solutionand attains the minimum at the cloud point of ethanol. The optimal composition ratio of binary organic solvents coin-cides to that near the cloud point and the optimal condition of binary organic solvents can be predicted.展开更多
The aim of this study was to prepare arsenic trioxide （ATO）-loaded stealth PEGylated PLGA nanoparticles （PEG-PLGA-NPs） and to assess the merits of PEG-PLGA-NPs as drug carriers for ATO delivery. PEG-PLGA copolymer...The aim of this study was to prepare arsenic trioxide （ATO）-loaded stealth PEGylated PLGA nanoparticles （PEG-PLGA-NPs） and to assess the merits of PEG-PLGA-NPs as drug carriers for ATO delivery. PEG-PLGA copolymer was synthesized with methoxypolyethyleneglycol （Mw=5000）, D, L-lactide, and glycolide by the ring-opening polymerization method. Amorphous ATO was transformed into cubic crystal form to increase its solu-bility in the organic solvent. ATO-loaded PEG-PLGA-NPs were prepared by the modified spontaneous emulsification solvent diffusion （SESD） method, and the main experimental factors influencing the characteristics of nanopar- ticles were investigated, to optimize the preparation. To confirm the escape of PEG-PLGA-NPs from phagocytosis by phagocytes, PEG-PLGA-NPs labeled rhodamine B uptake by murine peritoneal macrophages （MPM） were analyzed by flow cytometry. The results showed that the physicochemical characteristics of PEG-PLGA-NPs were affected by the type and concentration of the emulsifiers, polymer concentration, and drug concentration. ATO-loaded PEG-PLGA-NPs, with particle size of 120.8nm, zeta potential of-10.73mV, encapsulation efficiency of 73.6%, and drug loading of 1.36%, were prepared under optimal conditions. The images of transmission electron micros-copy （TEM） indicated that the optimized nanoparticles were near spherical and without aggregation or adhesion. The release experiments in vitro showed the ATO release from PEG-PLGA-NPs exhibited consequently sustained release for more than 26d, which was in accordance with Higuchi equation. The uptake of PEG-PLGA-NPs by MPM was found to decrease markedly compared to PLGA-NPs. The experimental results showed that PEG-PLGA-NPs were potential nano drug delivery carriers for ATO.展开更多
Valsartan has shown to be effective against diabetic neuropathy.In this study we designed,developed and characterized valsartan loaded solid lipid nanoparticles to enhance the protection against diabetic neuropathy.Ne...Valsartan has shown to be effective against diabetic neuropathy.In this study we designed,developed and characterized valsartan loaded solid lipid nanoparticles to enhance the protection against diabetic neuropathy.Nerve function parameters and behavioural studies were performed in male mice.Valsartan-loaded solid lipid nanoparticles(VSLNs)were formulated using palmitic acid as lipid and poloxamer188 as surfactant by solvent diffusion method.VSLNs were characterized for particle size and zeta potential analysis,morphology,drug entrapment efficiency and drug loading.In vitro drug release studies were performed in phosphate buffer of pH 7.4 by using dialysis bag method.In vivo studies such as motor nerve conduction velocity,thermal nociception and mechanical nociception studies were performed with both VSLNs and pure drug.The optimized batch was the one with 1:2 ratio of drug and lipid,and 1%surfactant was found to have the particle size of 457 nm,zeta potential of-16 mV,entrapment efficiency of 78.9±0.05%,drug loading of 26.22±0.05%and in vitro drug release of 84.84±0.07%over a period of 24 h.Based on these results,we concluded that VSLNs showed better protection from diabetic neuropathy.展开更多
基金Project ( 2001AA218011) supported by the National High Technology Development "863" Program of China
文摘The nanoparticles of polylactide (PLA) and poly(lactide-co-glycolide) (PLGA) were prepared by the bi-nary organic solvent diffusion method. The yield, particle size and size distribution of these nanoparticles wereevaluated. The yield of nanoparticles prepared by this method is over 90%, and the average size of the nanoparticlesis between 130-180 nm. In order to clarify the effect of the organic solvent used in the system on nanoparticle yieldand size, the cloud points of PLA and PLGA were examined by cloud point titration. The results indicate that theyields of nanoparticles increase with the increase of ethanol in the acetone solution and attain the maximum at thecloud point of ethanol, while the size of nanoparticles decreases with the increase of ethanol in the acetone solutionand attains the minimum at the cloud point of ethanol. The optimal composition ratio of binary organic solvents coin-cides to that near the cloud point and the optimal condition of binary organic solvents can be predicted.
基金Supported by the Special Funds for Major State Basic Research Program of China (973 Program, No.2007CB935800)theNational High Technology Research and Development Program of China (863 Program, No.2004AA215162).
文摘The aim of this study was to prepare arsenic trioxide （ATO）-loaded stealth PEGylated PLGA nanoparticles （PEG-PLGA-NPs） and to assess the merits of PEG-PLGA-NPs as drug carriers for ATO delivery. PEG-PLGA copolymer was synthesized with methoxypolyethyleneglycol （Mw=5000）, D, L-lactide, and glycolide by the ring-opening polymerization method. Amorphous ATO was transformed into cubic crystal form to increase its solu-bility in the organic solvent. ATO-loaded PEG-PLGA-NPs were prepared by the modified spontaneous emulsification solvent diffusion （SESD） method, and the main experimental factors influencing the characteristics of nanopar- ticles were investigated, to optimize the preparation. To confirm the escape of PEG-PLGA-NPs from phagocytosis by phagocytes, PEG-PLGA-NPs labeled rhodamine B uptake by murine peritoneal macrophages （MPM） were analyzed by flow cytometry. The results showed that the physicochemical characteristics of PEG-PLGA-NPs were affected by the type and concentration of the emulsifiers, polymer concentration, and drug concentration. ATO-loaded PEG-PLGA-NPs, with particle size of 120.8nm, zeta potential of-10.73mV, encapsulation efficiency of 73.6%, and drug loading of 1.36%, were prepared under optimal conditions. The images of transmission electron micros-copy （TEM） indicated that the optimized nanoparticles were near spherical and without aggregation or adhesion. The release experiments in vitro showed the ATO release from PEG-PLGA-NPs exhibited consequently sustained release for more than 26d, which was in accordance with Higuchi equation. The uptake of PEG-PLGA-NPs by MPM was found to decrease markedly compared to PLGA-NPs. The experimental results showed that PEG-PLGA-NPs were potential nano drug delivery carriers for ATO.
文摘Valsartan has shown to be effective against diabetic neuropathy.In this study we designed,developed and characterized valsartan loaded solid lipid nanoparticles to enhance the protection against diabetic neuropathy.Nerve function parameters and behavioural studies were performed in male mice.Valsartan-loaded solid lipid nanoparticles(VSLNs)were formulated using palmitic acid as lipid and poloxamer188 as surfactant by solvent diffusion method.VSLNs were characterized for particle size and zeta potential analysis,morphology,drug entrapment efficiency and drug loading.In vitro drug release studies were performed in phosphate buffer of pH 7.4 by using dialysis bag method.In vivo studies such as motor nerve conduction velocity,thermal nociception and mechanical nociception studies were performed with both VSLNs and pure drug.The optimized batch was the one with 1:2 ratio of drug and lipid,and 1%surfactant was found to have the particle size of 457 nm,zeta potential of-16 mV,entrapment efficiency of 78.9±0.05%,drug loading of 26.22±0.05%and in vitro drug release of 84.84±0.07%over a period of 24 h.Based on these results,we concluded that VSLNs showed better protection from diabetic neuropathy.
